Response of Normal Tissues to Boron Neutron Capture Therapy (BNCT) with <sup>10</sup>B-Borocaptate Sodium (BSH) and <sup>10</sup>B-Paraboronophenylalanine (BPA)
Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy that utilizes the cancer targeting <sup>10</sup>B-compound. Cancer cells that take up the compound are substantially damaged by the high liner energy transfer (LET) particles emitted mainly from the <sup>10<...
Guardado en:
Autor principal: | Hiroshi Fukuda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/242afb52f4eb4a05a5e7dd73eca2140d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using <sup>10</sup>B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
por: Hiroshi Fukuda
Publicado: (2021) -
Polymer-Coated Nanoparticles for Therapeutic and Diagnostic Non-<sup>10</sup>B Enriched Polymer-Coated Boron Carbon Oxynitride (BCNO) Nanoparticles as Potent BNCT Drug
por: Chen-Wei Chiang, et al.
Publicado: (2021) -
Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy
por: Chen J, et al.
Publicado: (2019) -
Comparison of Conventional and Radiomic Features between <sup>18</sup>F-FBPA PET/CT and PET/MR
por: Chien-Yi Liao, et al.
Publicado: (2021) -
Phenotype remodeling in neutrophilic granulocyte subsets CD64<sup>-</sup>CD32<sup>+</sup>CD16<sup>+</sup>CD11B<sup>+</sup>NG, CD64<sup>+</sup>CD32<sup>+</sup>CD16<sup>+</sup>CD11B<sup>+</sup>NG in <i>de novo</i> experimental model of viral-bacterial infection <i>in vitro</i>
por: I. V. Nesterova, et al.
Publicado: (2021)